Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Diabetes Drugs
- Type 1 Diabetes Drugs
- Type 2 Diabetes Drugs

Diabetes Drugs Newsletter

Some Diabetes Drug Classes Show Promise in Reducing AD Risk 25 Sep 2025 11:25 GMT
TOPLINE: Among diabetes drugs, GLP-1 receptor agonists and …
RA and Forbion back Sparrow's $95M Series B for type 2 diabetes drug 24 Sep 2025 13:41 GMT
After FDA Rejection, Lexicon’s Type 1 Diabetes Drug Hit With Another Regulatory Delay 23 Sep 2025 12:59 GMT
Lexicon Pharmaceuticals will wait a few months more on moving Zynquista forward in type 1 diabetes, after the FDA requested more time to review the biotech’s additional submissions for the drug. Following a complete response letter in December 2024, the …
Lexicon expects delay in FDA feedback on additional data for its diabetes drug 22 Sep 2025 21:24 GMT
(Reuters) -Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's previously submitted additional data on its experimental drug, zynquista, for patients with type 1 diabetes. The health …
Morphic Medical marks first commercial use of obesity, diabetes treatment in UK 22 Sep 2025 19:58 GMT
Morphic Medical said its non-surgical treatment for obesity and type 2 diabetes, RESET, has been used for the first time outside of a clinical trial, marking a milestone in the therapy’s rollout across Europe. The procedure was performed Sept. 19 at King’s …
Repurposing a Diabetes Medication to Prime CAR-T Cancer Targets 22 Sep 2025 18:23 GMT
… with an older class of diabetes drugs called thiazolidinediones, to enhance NECTIN4 … expression. Interestingly, we repurposed older diabetes drugs, including rosiglitazone and pioglitazone, both …
Common diabetes drug could reduce risk of Long COVID in people with obesity, study finds 22 Sep 2025 06:29 GMT
… with obesity who took the diabetes drug metformin after a COVID-19 …
Type 2 diabetes drug demonstrates anti-aging potential for people with the condition 21 Sep 2025 05:09 GMT
… account, an approach which combines diabetes treatment with managing aging biomarkers could …
Phage-Based Screening Platform Identifies Peptides With Therapeutic Potential 25 Sep 2025 17:26 GMT
… this is a type-2 diabetes drug approved by the United States …
Managing reciprocity of sleep and cardiometabolic health 25 Sep 2025 16:19 GMT
… , a cholesterol drug and a diabetes drug if you treat diabetes upstream …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS